Indian Equities Drop Amid Oil Spikes and US Tariffs
Indian equity benchmarks opened lower on July 23 as rising crude oil prices and proposed U.S. pharmaceutical tariffs weighed on investor sentiment.
Indian equity benchmarks, the Sensex and Nifty, opened lower on July 23, 2026, driven by a combination of geopolitical instability and poor corporate earnings. Brent crude prices surged past $96 per barrel following military strikes by the United States on Iran and attacks by Yemen's Houthis on Saudi Arabian tankers in the Red Sea.
Market pressure intensified as the United States proposed steep tariffs on generic pharmaceutical imports scheduled to begin in 2028. These headwinds contributed to a significant decline in the pharmaceutical sector, with Dr Reddy's Laboratories seeing shares hit a 52-week low after reporting a 69% drop in first-quarter profit. The energy sector also struggled, highlighted by Hindustan Petroleum reporting a consolidated net loss of approximately ₹12,265 crore.
While the Nifty Oil & Gas and Pharma sectors were the worst performers, the FMCG and MidSmall IT & Telecom sectors remained in the green. The Reserve Bank of India likely intervened in the foreign exchange market to mitigate losses for the rupee amid the volatility.